Albumin’s established role in cirrhosis, effectively managing complications like LVP, AKI, HRS-AKI, and SBP, contrasts with its emerging but complex role in sepsis, where treatment is complicated by the disease’s heterogeneity [48,62]. This evidence concerns the gene ALB and acute kidney injury.